Bo Li

机构：Capital Medical University, Sichuan University, Tianjin Medical University Cancer Institute and Hospital, Chinese PLA General Hospital, Wenzhou Hospital of Traditional Chinese Medicine, West China Hospital of Sichuan University, Gansu University of Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing YouAn Hospital · ORCID：0000-0002-1959-1301

发表论文 78 篇 · 总被引 1287 次 · h-index 19

代表论文

• Combined utility of Ki-67 index and tumor grade to stratify patients with pancreatic ductal adenocarcinoma who underwent upfront surgery (2023 · BMC Surgery · 被引 8)
• Real‐world effectiveness of adjuvant octreotide therapy in patients with pancreatic neuroendocrine tumors at high recurrence risk: A multicenter retrospective cohort study (2024 · Journal of Neuroendocrinology · 被引 7)
• A novel staging system derived from natural language processing of pathology reports to predict prognostic outcomes of pancreatic cancer: a retrospective cohort study (2023 · International Journal of Surgery · 被引 3)
• The OGG1 Ser326Cys polymorphism: molecular mechanisms of disease susceptibility and precision medicine applications (2025 · Clinical Epigenetics · 被引 2)
• Novel designed balloon specialized for EUS-guided gastroenterostomy: A pilot study (2025 · Endoscopic Ultrasound · 被引 2)
• Morphomolecular staging to improve stratification of patients with node-negative pancreatic cancer (2023 · British journal of surgery · 被引 2)